Alfred Lam

62PUBLICATIONS
86CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologySolid tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (62)

|Sep 09, 2026
A phase II trial of chemotherapy-free neoadjuvant camrelizumab plus apatinib for resectable HNSCC: pathological response and vascular-immune crosstalk.

|Mar 16, 2026
Genetic Alterations Involved in Immune Escape Mechanisms of Circulating Tumour Cells in Colorectal Carcinogenesis.

Sharmin Aktar, Matthew Masoudi, Dilpreet Moti

|Sep 16, 2025
Metabolic Reprogramming of Cancer Cells and Therapeutics Targeting Cancer Metabolism.

Jilsy M J Punnasseril, Abdul Auwal, Vinod Gopalan

|Aug 12, 2025
Rising incidence of follicular thyroid carcinoma and oncocytic carcinoma of the thyroid in Australia.

Steven Weller, Cordia Chu, Alfred King-Yin Lam

|Aug 08, 2025
Oncogenic NFE2L2 mutations in plasma ctDNA and tumors are predictors and prognosticators of chemoradiation therapy in resectable esophageal squamous cell carcinoma.

Josephine Mun-Yee Ko, Chen Guo, Alvin Ka-Kiu Leung

|Jul 08, 2025
Making Medical Education Socially Accountable in Australia and Southeast Asia: A Systematic Review.

Jyotsna Rimal, Ashish Shrestha, Elizabeth Cardell

Pageof 11

Frequent Collaborators

8 joint publications

Vinod Gopalan

5 joint publications

Amir Avan

4 joint publications

Farhadul Islam

4 joint publications

Elisa Giovannetti